144 related articles for article (PubMed ID: 1429225)
1. Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties.
Takahashi H; Osada H; Koshino H; Kudo T; Amano S; Shimizu S; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1409-13. PubMed ID: 1429225
[TBL] [Abstract][Full Text] [Related]
2. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor.
Osada H; Koshino H; Isono K; Takahashi H; Kawanishi G
J Antibiot (Tokyo); 1991 Feb; 44(2):259-61. PubMed ID: 2010365
[No Abstract] [Full Text] [Related]
3. Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycins A, B, C and D.
Koshino H; Takahashi H; Osada H; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1420-7. PubMed ID: 1429227
[TBL] [Abstract][Full Text] [Related]
4. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities.
Takahashi H; Osada H; Koshino H; Sasaki M; Onose R; Nakakoshi M; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1414-9. PubMed ID: 1429226
[TBL] [Abstract][Full Text] [Related]
5. Reveromycins revealed: new polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts.
Fremlin L; Farrugia M; Piggott AM; Khalil Z; Lacey E; Capon RJ
Org Biomol Chem; 2011 Feb; 9(4):1201-11. PubMed ID: 21152660
[TBL] [Abstract][Full Text] [Related]
6. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus.
Manam RR; Teisan S; White DJ; Nicholson B; Grodberg J; Neuteboom ST; Lam KS; Mosca DA; Lloyd GK; Potts BC
J Nat Prod; 2005 Feb; 68(2):240-3. PubMed ID: 15730252
[TBL] [Abstract][Full Text] [Related]
7. Isolation and structure elucidation of 7,8-dideoxy-6-oxo-griseorhodin C produced by Actinoplanes ianthinogenes.
Panzone G; Trani A; Ferrari P; Gastaldo L; Colombo L
J Antibiot (Tokyo); 1997 Aug; 50(8):665-70. PubMed ID: 9315079
[TBL] [Abstract][Full Text] [Related]
8. C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties.
Haxell MA; Bishop BF; Bryce P; Gration KA; Kara H; Monday RA; Pacey MS; Perry DA; Kojima Y; Maeda H
J Antibiot (Tokyo); 1992 May; 45(5):659-70. PubMed ID: 1624368
[TBL] [Abstract][Full Text] [Related]
9. New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
Nakajima H; Sato B; Fujita T; Takase S; Terano H; Okuhara M
J Antibiot (Tokyo); 1996 Dec; 49(12):1196-203. PubMed ID: 9031664
[TBL] [Abstract][Full Text] [Related]
10. Aldecalmycin, a new antimicrobial antibiotic from Streptomyces. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties.
Sawa R; Takahashi Y; Itoh S; Shimanaka K; Kinoshita N; Homma Y; Hamada M; Sawa T; Naganawa H; Takeuchi T
J Antibiot (Tokyo); 1994 Nov; 47(11):1266-72. PubMed ID: 8002389
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
Drouet KE; Ling T; Tran HV; Theodorakis EA
Org Lett; 2000 Jan; 2(2):207-10. PubMed ID: 10814283
[TBL] [Abstract][Full Text] [Related]
12. 16-Methyloxazolomycin, a new antimicrobial and cytotoxic substance produced by a Streptomyces sp.
Ryu G; Hwang S; Kim SK
J Antibiot (Tokyo); 1997 Dec; 50(12):1064-6. PubMed ID: 9510916
[No Abstract] [Full Text] [Related]
13. New cytotoxic agents, BE-52440A and B, produced by a streptomycete.
Tsukamoto M; Nakajima S; Murooka K; Naito M; Suzuki H; Hirayama M; Hirano K; Kojiri K; Suda H
J Antibiot (Tokyo); 2000 Jul; 53(7):687-93. PubMed ID: 10994810
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification of reveromycin A and its biological activities.
Shimizu T; Usui T; Machida K; Furuya K; Osada H; Nakata T
Bioorg Med Chem Lett; 2002 Dec; 12(23):3363-6. PubMed ID: 12419362
[TBL] [Abstract][Full Text] [Related]
15. Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation.
Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
J Antibiot (Tokyo); 1993 Oct; 46(10):1536-49. PubMed ID: 8244881
[TBL] [Abstract][Full Text] [Related]
16. Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity.
Sanglier JJ; Quesniaux V; Fehr T; Hofmann H; Mahnke M; Memmert K; Schuler W; Zenke G; Gschwind L; Maurer C; Schilling W
J Antibiot (Tokyo); 1999 May; 52(5):466-73. PubMed ID: 10480570
[TBL] [Abstract][Full Text] [Related]
17. Novel bioactive oxazolomycin isomers produced by Streptomyces albus JA3453.
Kanzaki H; Wada K; Nitoda T; Kawazu K
Biosci Biotechnol Biochem; 1998 Mar; 62(3):438-42. PubMed ID: 9571773
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic Analogues.
He H; Ratnayake AS; Janso JE; He M; Yang HY; Loganzo F; Shor B; O'Donnell CJ; Koehn FE
J Nat Prod; 2014 Aug; 77(8):1864-70. PubMed ID: 25098528
[TBL] [Abstract][Full Text] [Related]
19. Metabolic products of microorganisms. 264. Exfoliamycin and related metabolites, new naphthoquinone antibiotics from Streptomyces exfoliatus.
Potterat O; Zähner H; Volkmann C; Zeeck A
J Antibiot (Tokyo); 1993 Feb; 46(2):346-9. PubMed ID: 8468251
[No Abstract] [Full Text] [Related]
20. Cytosaminomycins, new anticoccidial agents produced by Streptomyces sp. KO-8119. I. Taxonomy, production, isolation and physico-chemical and biological properties.
Haneda K; Shinose M; Seino A; Tabata N; Tomoda H; Iwai Y; Omura S
J Antibiot (Tokyo); 1994 Jul; 47(7):774-81. PubMed ID: 8071122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
